Orbis partners with pharmaceutical companies to optimize their product portfolios by integrating its novel microparticulate technology. Utilizing Precision Particle Fabrication technology, Orbis provides innovative non-adherence solutions for oral and injectable pharmaceutical products in a single-step process, developing customized formulations and intellectual property for product manufacture with scaled cGMP Phase 1 manufacturing capabilities.
Keine Kommentare verfügbar.
Bewertung & Kommentar hinterlassen